Nationwide Fund Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-9,861
| Closed | -$145K | – | 2388 |
|
|
2017
Q3 | $145K | Hold |
9,861
| – | – | ﹤0.01% | 2763 |
|
|
2017
Q2 | $138K | Hold |
9,861
| – | – | ﹤0.01% | 2770 |
|
|
2017
Q1 | $168K | Sell |
9,861
-7,506
| -43% | -$128K | ﹤0.01% | 2663 |
|
|
2016
Q4 | $179K | Sell |
17,367
-19,083
| -52% | -$197K | ﹤0.01% | 2660 |
|
|
2016
Q3 | $369K | Sell |
36,450
-970
| -3% | -$9.82K | ﹤0.01% | 2324 |
|
|
2016
Q2 | $420K | Buy |
37,420
+322
| +0.9% | +$3.61K | ﹤0.01% | 2240 |
|
|
2016
Q1 | $507K | Buy |
37,098
+26,900
| +264% | +$368K | ﹤0.01% | 2087 |
|
|
2015
Q4 | $193K | Buy |
10,198
+313
| +3% | +$5.92K | ﹤0.01% | 2577 |
|
|
2015
Q3 | $186K | Hold |
9,885
| – | – | ﹤0.01% | 2598 |
|
|
2015
Q2 | $147K | Buy |
+9,885
| New | +$147K | ﹤0.01% | 2877 |
|
|
2014
Q2 | – | Sell |
-14,746
| Closed | -$198K | – | 3400 |
|
|
2014
Q1 | $198K | Buy |
+14,746
| New | +$198K | ﹤0.01% | 2490 |
|